Coverage
-
October 23, 2020
Lannett Company Inc. and its stockholders secured a Delaware federal court's approval late Thursday for a settlement to end a suit accusing the company of lying to investors about the pharmaceutical company's part in multi-district government price-fixing probes and litigation.
1 other articles on this case.
View all »